Identifying barriers and disparities in the healthcare of patients with alopecia areata: a mixed-methods analysis using claims data and qualitative interview data
Objectives Alopecia areata (AA) is a chronic immune-related disease with non-scarring hair loss. Treatment may reduce disease activity but cannot cure. Even though AA can be very burdensome to patients, the German social act has categorised AA as a ‘lifestyle disease’ and treatment is not covered by...
Saved in:
| Main Authors: | Matthias Augustin, Christine Blome, Katharina Müller, Kristina Hagenström, Toni Maria Janke, Beke Hester, Theresa Klinger, Brigitte Stephan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/5/e098802.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of Drug Supply for Psoriasis from 2010 to 2022 – Real-World Claims Data Analysis in Germany
by: Hagenström K, et al.
Published: (2025-06-01) -
Janus kinase inhibitors for alopecia areata: a review of clinical data
by: Yutong Sun, et al.
Published: (2025-05-01) -
Alopecia Areata: Pathogenesis, Diagnosis, and Therapies
by: Tianyou Ma, et al.
Published: (2025-05-01) -
Modern Management Approaches for Alopecia Areata
by: Eduard T. Ambarchyan, et al.
Published: (2024-12-01) -
To evaluate the role of interleukin-6 in alopecia areata
by: Sobia Wali Muhammad, et al.
Published: (2024-04-01)